Contraindicated (one)bortezomib will increase the degree or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism. Contraindicated. Solid or average CYP2C19 inhibitors might increase mavacamten systemic exposure, causing heart failure as a result of systolic dysfunction. Evidently for speed, the Nagari begun earning the highest line additional like a curve https://harryd332ozk5.like-blogs.com/profile